Idiopathic pulmonary fibrosis.

The most common signs and symptoms of idiopathic pulmonary fibrosis are shortness of breath and a persistent dry, hacking cough. Many affected individuals also experience a loss of appetite and gradual weight loss. Some people with idiopathic pulmonary fibrosis develop widened and rounded tips of the fingers and toes (clubbing) resulting from a shortage of oxygen. These features are relatively nonspecific; not everyone with these health problems has idiopathic pulmonary fibrosis. Other respiratory diseases, some of which are less serious, can cause similar signs and symptoms.

[1]  D. Schwartz,et al.  Pulmonary Fibrosis, Familial , 2015 .

[2]  T. Hartman,et al.  Idiopathic pulmonary fibrosis: evolving concepts. , 2014, Mayo Clinic proceedings.

[3]  Joyce S Lee,et al.  Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. , 2014, The Lancet. Respiratory medicine.

[4]  I. Rosas,et al.  Genetics and early detection in idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.

[5]  T. Zheng,et al.  Genetic architecture of human fibrotic diseases: disease risk and disease progression , 2013, Front. Pharmacol..

[6]  Ankur Girdhar,et al.  Approach to acute exacerbation of idiopathic pulmonary fibrosis , 2013, Annals of thoracic medicine.

[7]  N. Ting,et al.  hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms , 2012, Aging cell.

[8]  Gang Liu,et al.  New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis , 2011, Drugs.

[9]  J. Roman,et al.  Management of Idiopathic Pulmonary Fibrosis , 2011, The American journal of the medical sciences.

[10]  M. Gershwin,et al.  Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review , 2011, Clinical reviews in allergy & immunology.

[11]  F. Tubach,et al.  Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[12]  H. Hauber,et al.  Current and future treatment options in idiopathic pulmonary fibrosis. , 2010, Inflammation & allergy drug targets.

[13]  S. Harari,et al.  IPF: new insight on pathogenesis and treatment , 2010, Allergy.

[14]  P. Sime,et al.  Determinants of initiation and progression of idiopathic pulmonary fibrosis , 2009, Respirology.

[15]  V. Aidinis,et al.  Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[16]  Chao Xing,et al.  Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.

[17]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[18]  T. Hartman,et al.  Familial idiopathic pulmonary fibrosis: clinical features and outcome. , 2005, Chest.

[19]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .